Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.

What you'll get out of this episode:

• Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
• Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
• Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
• Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
• Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.

What you'll get out of this episode:

• Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.
• Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.
• Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.
• Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.
• Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/
Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/
Website http://www.ontargetlabs.com

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Frank Watanabe, President & CEO at Arcutis Biotherapeutics.

What you'll get out of this episode:

• Company Focus: Arcutis Biotherapeutics, under Frank Watanabe, is dedicated to treating inflammatory skin conditions, with three FDA-approved products and a fourth pending.
• Significant Milestones: This year, Arcutis launched two new products and partnered with a primary care company to expand its reach.
• Patient-Centric Approach: Arcutis prioritizes patient needs by involving dermatology practitioners and patient insights directly in decision-making.
• Technological Perspective: While acknowledging AI's potential in drug discovery, Arcutis is focused on tangible, current advancements without prematurely implementing AI.
• Expanding Accessibility: Arcutis is actively working to extend its treatments to Medicare and Medicaid markets to support a broader patient demographic.

To Learn More About Our Guest And Their Company:
LinkedIn https://www.linkedin.com/in/frank-watanabe-419711/
Company LinkedIn https://www.linkedin.com/company/arcutis-inc/
Website https://www.arcutis.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/